AbbVie said its experimental drug improved symptoms of rheumatoid arthritis in patients in two mid-stage studies.» Read More
How Alzheimer's drug Solanezumab works to help treat the underlying cause of the disease, with CNBC's Meg Tirrell.
Costco has been subpoenaed by the federal government concerning prescriptions for controlled substances.
CNBC's Meg Tirrell provides insight to what Foundation Medicine, a cancer testing company, can do to better inform doctors on cancer via a database filled with research.
A new plan for Express Scripts regarding cancer drugs, with CNBC's Meg Tirrell.
CHICAGO, May 22- Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals. Wal-Mart, the country's biggest food retailer, is also telling suppliers not to raise animals in gestation crates or in...
CHICAGO, May 22- Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take a stand against the excessive use of drugs in raising farm animals. Wal-Mart, the country's biggest food retailer, is also telling suppliers not to raise animals in gestation crates or in other...
*Deal values Omnicare at $12.7 bln, including $2.3 B debt. May 21- Drugstore operator CVS Health Corp said Thursday it will spend $10.1 billion to buy Omnicare Inc, a company that supplies prescription medicines to nursing, assisted living and other healthcare facilities. They could renegotiate their supply contracts given the volume, "said FBR analyst Steven...
BT Slingsby, CEO of the Global Health Innovative Technology Fund (GHIT), explains why it is developing new innovative health technologies to combat diseases like tuberculosis and malaria.
The American Society of Clinical Oncology conference will occur at the end of May in Chicago. CNBC's Meg Tirrell reports which companies investors should watch. Also, Les Funtleyder, ESquared Asset Management, shares his view.
A new report says the number of Americans being billed more than $100,000 a year for their prescriptions has tripled in the past year. CNBC's Meg Tirrell breaks down the report, saying slightly more than half of the spenders were men.
CARACAS, May 6- Venezuela is investigating whether drug companies including Germany's Merck KGaA and Bayer AG have improperly profited from subsidized foreign exchange amid growing medicine shortages, the country's health minister said. Those firms have received a favorable exchange rate through Venezuela's currency controls to produce or import...
May 1- CVS Health Corp reported higher-than-expected quarterly results on Friday, helped by increased revenue from its specialty pharmacy services and increased claim processing. CVS, the No. 2 U.S. drugstore operator, also raised the low end of its 2015 profit forecast to $5.08 a share from $5.05 before special items, while keeping the high end at 5.19.
April 9- Drugstore operator Walgreens Boots Alliance Inc on Thursday reported a higher-than-expected quarterly profit and said it would widen its cost-cutting program, sending its shares higher. Walgreens said on Thursday that it had identified ways to increase the program to a projected $1.5 billion by the August year-end of fiscal 2017..
April 8- Rite Aid Corp reported a better-than-expected quarterly profit on Wednesday, and expected a renewed distribution agreement with McKesson Corp along with the remodeling of its wellness stores to benefit fiscal 2016 earnings. Rite Aid is the No. 3 drugstore chain by sales in the U.S. behind Walgreen Boots Alliance and CVS Health Corp.
April 8- Drugstore chain operator Rite Aid Corp's quarterly revenue rose 3.8 percent, helped by strong prescription sales that drove better-than-expected same-store sales growth. Rite Aid's shares rose 2.9 percent to $8.95 in premarket trading on Wednesday. The latest quarter included an income tax benefit of $1.72 billion, or $1.67 per share, Rite Aid said.
Music icon Willie Nelson is going into the weed business, according to a pot activist.
Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.
Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.
CNBC's Jane Wells shares her top three predictions for the pot industry this year, including changing bank regulations and the beginning of voters' remorse where it's legal.
U.S. drugstore chain operator Walgreen reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled.